NL-OMON41394
Recruiting
Not Applicable
Determining the sensitivity and specificity of circulating tumor cells and cytology in cerebrospinal fluid of patients clinically suspected for leptomeningeal metastases - N12CLM (Identification of Circulating tumor cells in CSF)
Antoni van Leeuwenhoek Ziekenhuis0 sites80 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- leptomeningeal metastasis
- Sponsor
- Antoni van Leeuwenhoek Ziekenhuis
- Enrollment
- 80
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who are treated for advanced EpCam positive solid tumors (such as breast cancer, lung cancer, gastrointestinal cancer) or melanoma
- •2\. Age \>\=18 years;
- •3\. Able and willing to give written informed consent;
- •4\. WHO performance status of 0, 1, 2, 3 or 4;
- •5\. Able and willing to undergo lumbar puncture and veni\-puncture.
Exclusion Criteria
- •Lumbar puncture not clinically / diagnostically indicated
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Determination of sensitivity and specificity of five solutions of allergen extract (5 grasses, birch, ragweed pollens and Dermatophagoides pteronyssinus and Dermatophagoides farinae mites) for diagnosis by skin prick testing. - Sensitivity and specificity of solutions for diagnosis by skin prick-testEUCTR2010-020079-22-FRSTALLERGENES S.A.
Active, not recruiting
Phase 1
Evaluation the sensitivity and specificity of a novel diagnostic kit for the detection of placental alpha-microglobulin-1 (PAMG-1) in the prediction of preterm birthPreterm birthPAMG ǃ positivePAMGǃ negativeTCTR20180703002no160
Completed
Not Applicable
Evaluation of the Sensitivity and Specificity of three Point of Care Tests (POCT) for Determination of SARS-Cov-2 (COVID-19), including a User Performance Evaluation for two devicesSARS-CoV-2 Infection StatusDRKS00025374MED TRUST Handelsges.m.b.H.200
Completed
Not Applicable
se of [-2]proPSA for the detection of prostate cancer in patients who are candidate for prostatic biopsyProstate cancerCancerMalignant neoplasm of prostateISRCTN04707454Beckman Coulter Eurocenter (Switzerland)1,250
Not yet recruiting
Not Applicable
Reappraise of sensitivity and specificity detecting fatty liver using ultrasonography with MRI proton density fat fraction as the reference standardDiseases of the digestive systemKCT0002266Hanyang University Seoul Hospital184